| D |
2026-05-05 17:11 |
2026-05-01 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
M - OptEx |
$0.00 |
+1,373 |
20.5K |
+7% |
$0 |
| D |
2026-05-05 17:11 |
2026-05-01 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
J - Other |
$0.00 |
-203 |
20.3K |
-1.0% |
$0 |
| D |
2026-05-05 17:11 |
2026-05-01 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
F - Tax |
$58.22 |
-599 |
19.7K |
-3% |
-$34.9K |
| DM |
2026-03-12 |
2026-03-10 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
F - Tax |
$60.13 |
-7,015 |
13.2K |
-35% |
-$421.8K |
| DM |
2026-03-12 |
2026-03-10 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
M - OptEx |
$0.00 |
+24.1K |
15.2K |
New |
$0 |
| DM |
2026-03-12 |
2026-03-10 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
J - Other |
$0.00 |
-10.4K |
15.0K |
-41% |
$0 |
| DM |
2025-03-12 |
2025-03-10 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
J - Other |
$0.00 |
-4,830 |
8,423 |
-36% |
$0 |
| DM |
2025-03-12 |
2025-03-10 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
M - OptEx |
$0.00 |
+16.7K |
8,554 |
New |
$0 |
| DM |
2025-03-12 |
2025-03-10 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
F - Tax |
$63.11 |
-6,065 |
8,252 |
-42% |
-$382.8K |
| DM |
2024-03-12 |
2024-03-10 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
F - Tax |
$53.79 |
-4,323 |
6,650 |
-39% |
-$232.5K |
| DM |
2024-03-12 |
2024-03-10 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
M - OptEx |
$0.00 |
+15.0K |
2,224 |
New |
$0 |
| DM |
2024-03-12 |
2024-03-10 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
J - Other |
$0.00 |
-4,569 |
9,885 |
-32% |
$0 |
| D |
2023-06-06 |
2023-06-03 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
F - Tax |
$65.66 |
-551 |
526 |
-51% |
-$36.2K |
| D |
2023-06-06 |
2023-06-03 |
BMY |
Bristol Myers Squibb |
Lenkowsky Adam |
EVP, Chief Commercial Off |
M - OptEx |
$0.00 |
+1,077 |
1,077 |
New |
$0 |